9,10-dimethyl-1,2-benzanthracene has been researched along with ro 13-6298 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollag, W; Hartmann, HR | 1 |
| Mahrle, G | 1 |
| Bollag, W | 1 |
3 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and ro 13-6298
| Article | Year |
|---|---|
The effects of arotinoids on rat mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoates; Body Weight; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Retinoids | 1985 |
Retinoids in skin cancer and hyperproliferative skin disease.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoates; Cell Differentiation; Cell Division; Guinea Pigs; Humans; Hyperplasia; In Vitro Techniques; Isotretinoin; Neoplasms, Experimental; Rabbits; Retinoids; Skin; Skin Neoplasms; Tretinoin; Vitamin A | 1983 |
Arotinoids. A new class of retinoids with activities in oncology and dermatology.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoates; Carcinoma; Dose-Response Relationship, Drug; Mice; Neoplasms, Experimental; Papilloma; Retinoids; Skin Neoplasms | 1981 |